Business / Finance

RSS
Bedfont® Scientific Ltd. achieves Platinum Business Award presented by Kent County Council (KCC)

Bedfont® Scientific Ltd. achieves Platinum Business Award presented by Kent County Council (KCC)

Flow Robotics takes sample traceability to the next level

Flow Robotics takes sample traceability to the next level

General Awareness Gaps and Affordability Concerns Revealed with State of Colorectal Cancer Awareness Report

General Awareness Gaps and Affordability Concerns Revealed with State of Colorectal Cancer Awareness Report

Seda: Winners of Bionow Business Growth Award 2022

Seda: Winners of Bionow Business Growth Award 2022

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

High quality, cost effective surgical retractor is welcomed by leading US hospital group

High quality, cost effective surgical retractor is welcomed by leading US hospital group

Ingenza appoints Steve Jones as its new Chief Financial Officer

Ingenza appoints Steve Jones as its new Chief Financial Officer

Grenova wins 2023 Gold Governor’s Environmental Excellence Award

Grenova wins 2023 Gold Governor’s Environmental Excellence Award

Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

J+D release FC365 Lite

J+D release FC365 Lite

INTEGRA Biosciences acquires Miroculus to accelerate genomics

INTEGRA Biosciences acquires Miroculus to accelerate genomics

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Bormioli Pharma announces robust growth in its North American business in 2022

Bormioli Pharma announces robust growth in its North American business in 2022

Bormioli Pharma North America sales grew by more than 40% in 2022

Bormioli Pharma North America sales grew by more than 40% in 2022

EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions

EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions

Veterans’ health administration expands deployment of Mikroscan Systems

Veterans’ health administration expands deployment of Mikroscan Systems

Decades of substantial U.S. Government investment in mRNA technology paved way for COVID-19 vaccines

Decades of substantial U.S. Government investment in mRNA technology paved way for COVID-19 vaccines

Festo breaks price/performance barriers with new multi-axis gantry

Festo breaks price/performance barriers with new multi-axis gantry

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.